Finding a safe dose of vinpocetine in healthy volunteers
Treatments studied
Part of Genetic & congenital, Women’s health & pregnancy clinical trials.
This study tests a drug called vinpocetine in healthy volunteers to find the safest dose. Vinpocetine may improve blood flow to the brain, but this trial is only for healthy people to check how the body handles it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 40 years old.
- You can speak and understand English well.
- You do not have major medical conditions like epilepsy, diabetes, heart disease, active cancer, or depression.
- You are not currently taking medications that affect the brain or nervous system.
- You are not allergic to vinpocetine.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether taking a choline supplement during pregnancy can reduce harmful effects on the baby when a person drinks heavily while pregnant. It may help support healthier pregnancy and baby outcomes for those who meet the study’s drinking and nutrition criteria.
This study tests a drug that targets a protein called TSPO to see if it can improve the function of the cells lining the small blood vessels in the brain of people with cerebral small vessel disease. It may help with mild memory or thinking problems.
This study tests whether giving vitamin B1 (thiamine) to people who drink heavily can reduce alcohol-related brain injury. It may help protect memory and thinking if you are currently drinking a lot.
This Phase 1 study tests how safe and well-tolerated a new experimental drug called VVZ-2471 is in healthy adults. The drug targets brain pathways involved in impulse control, and researchers want to understand its effects on people who naturally tend to act without thinking.
This is an early-stage safety study testing a new investigational drug (VH4770359) in healthy volunteers. Researchers want to understand how the body processes the drug and ensure it is safe and well-tolerated.
This trial tests a new drug (VB19055) in healthy volunteers to see how safe it is and how the body processes it. Participants will be watched closely and may help find the right dose for future studies.
Hear when a new Fetal Alcohol Spectrum Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.